SCHEMBL5645927

SCHEMBL5645927

CN(C(=O)Oc1ccc(CCNS(=O)(=O)c2ccc(N3CCOCC3)nc2)cc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.50
HSD17B10 Q99714 1/20 0.46
GAA P10253 1/20 0.44
HTT P42858 1/20 0.43
ALDH1A1 P00352 4/20 0.42
TBXA2R P21731 1/20 0.42
TBXAS1 P24557 1/20 0.42
KMT2A Q03164 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
PKM P14618 1/20 0.41
AOC3 Q16853 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
IRS1 P35568 1/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6628314 0.84 SGMS1 (0.49) KDM4EGAAHTTALDH1A1TBXA2R
SCHEMBL5646848 0.80 ALDH1A1 (0.49) GAAHTTALDH1A1TBXA2RTBXAS1
SCHEMBL5650194 0.80 LIPE (0.58) GAAALDH1A1TBXA2RTBXAS1POLB
SCHEMBL5647671 0.78 ALDH1A1 (0.54) ALDH1A1TBXA2RTBXAS1KMT2ALMNA
SCHEMBL5646623 0.78 ALDH1A1 (0.57) HTTALDH1A1TBXA2RTBXAS1KMT2A
SCHEMBL5651292 0.78 PRMT1 (0.59) HSD17B10ALDH1A1TBXA2RTBXAS1KMT2A
SCHEMBL5648412 0.77 HTT (0.54) HTTTBXA2RTBXAS1
SCHEMBL5647727 0.76 KMT2A (0.52) GAAALDH1A1TBXA2RTBXAS1KMT2A
SCHEMBL5644968 0.75 LMNA (0.49) ALDH1A1TBXA2RTBXAS1LMNASMN1; SMN2
SCHEMBL5644838 0.75 ALDH1A1 (0.67) GAAALDH1A1TBXA2RTBXAS1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060148860-A1 Substituted p-phenyl carbamates NOVO NORDISK A/S (DK) 2006-07-06 US claimed
EP-1636188-A1 PARA-SUBSTITUTED PHENYL CARBAMATES AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111006-A1 PARA-SUBTITUTED PHENYL CARBAMATES AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP claimed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US claimed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO claimed
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
US-20060148860-A1 Substituted p-phenyl carbamates NOVO NORDISK A/S (DK) 2006-07-06 US disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
EP-1636188-A1 PARA-SUBSTITUTED PHENYL CARBAMATES AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111006-A1 PARA-SUBTITUTED PHENYL CARBAMATES AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed
EP-1458375-A2 COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051842-A2 COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148860-A1 Substituted p-phenyl carbamates LIPE, PNLIP, LPL KDM4E 748/4885HSD17B10 306/4885GAA 35/4885
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL KDM4E 3457/4885HSD17B10 94/4885GAA 21/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL KDM4E 3778/4885HSD17B10 106/4885GAA 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.